Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0.784. It has been cited 185 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.784
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI
Grant: R01 CA197936
NCI
Grant: U24 CA213274
NIH
Grant: K08 CA-248723
NCI
Grant: P30 CA08748
NCI
Grant: P30-CA008748
NCI NIH HHS
Grant: K08 CA248723
NCI NIH HHS
Grant: R01 CA264078
NCI NIH HHS
Grant: P30 CA008748
MeSH Terms
Additional file 1 of SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing
Additional file 1 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 1 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 1 of Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer
Additional file 1 of Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer
Additional file 3 of Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer
Additional file 3 of Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer
Additional file 4 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 5 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 5 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 6 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 4 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 6 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 2 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 2 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 7 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq
Additional file 7 of Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq